UBS Group AG - ABEONA THERAPEUTICS INC ownership

ABEONA THERAPEUTICS INC's ticker is ABEO and the CUSIP is 00289Y107. A total of 57 filers reported holding ABEONA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ABEONA THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$9,0000.0%44,324
+52.6%
0.00%
Q1 2022$9,000
-25.0%
29,047
-17.5%
0.00%
Q4 2021$12,000
+140.0%
35,203
+666.4%
0.00%
Q3 2021$5,000
-68.8%
4,593
-56.1%
0.00%
Q2 2021$16,000
-46.7%
10,453
-35.2%
0.00%
Q1 2021$30,000
-3.2%
16,133
-19.0%
0.00%
Q4 2020$31,000
+158.3%
19,915
+76.2%
0.00%
Q3 2020$12,000
-84.8%
11,300
-58.3%
0.00%
Q2 2020$79,000
+17.9%
27,108
-14.6%
0.00%
Q1 2020$67,000
-50.4%
31,750
-23.3%
0.00%
Q4 2019$135,000
+132.8%
41,412
+62.4%
0.00%
Q3 2019$58,000
+16.0%
25,495
+144.9%
0.00%
Q2 2019$50,000
+4900.0%
10,410
+6794.0%
0.00%
Q1 2019$1,000
-99.1%
151
-99.0%
0.00%
Q4 2018$108,000
-74.7%
15,060
-54.9%
0.00%
Q3 2018$427,000
+1679.2%
33,367
+2123.0%
0.00%
Q2 2018$24,000
-98.9%
1,501
-99.0%
0.00%
-100.0%
Q1 2018$2,182,000
+23.6%
152,081
+36.5%
0.00%0.0%
Q4 2017$1,766,000
-14.4%
111,401
-8.0%
0.00%0.0%
Q3 2017$2,064,000
+20540.0%
121,056
+7670.0%
0.00%
Q2 2017$10,0001,558
+155700.0%
0.00%
Q1 2017$010.0%0.00%
Q4 2016$010.0%0.00%
Q3 2016$010.0%0.00%
Q2 2016$010.0%0.00%
Q1 2016$0
-100.0%
1
-99.8%
0.00%
Q4 2015$2,000567
+56600.0%
0.00%
Q3 2015$010.0%0.00%
Q2 2015$010.00%
Other shareholders
ABEONA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 2,859,767$4,490,0003.06%
Cedar Brook Financial Partners, LLC 55,000$86,0000.03%
ADAGE CAPITAL PARTNERS GP, L.L.C. 8,287,995$13,012,0000.03%
Platform Technology Partners 27,706$43,0000.02%
Virtu Financial LLC 118,030$185,0000.02%
WS MANAGEMENT LLLP 97,173$153,0000.02%
WEXFORD CAPITAL LP 26,597$42,0000.01%
MEITAV INVESTMENT HOUSE LTD 92,000$144,0000.01%
CAMBRIDGE TRUST CO 65,414$103,0000.01%
QS Investors, LLC 215,000$338,0000.00%
View complete list of ABEONA THERAPEUTICS INC shareholders